Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques

Endocrine

Volumn 33, Issue 3, 2008, Pages 285-293

  Henderson, J A ^a   Bethea, C L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Estradiol; Hormone therapy; Macaques; Progesterone; Raphe nucleus; Serotonin receptors

Indexed keywords

ANTIESTROGEN; ESTRADIOL; PROGESTERONE; RALOXIFENE; SEROTONIN 1A RECEPTOR; SEROTONIN 2C RECEPTOR;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG IMPLANT; ESTROGEN THERAPY; FEMALE; MACACA; METABOLISM; OVARIECTOMY; OVARY; PHYSIOLOGY; RAPHE NUCLEUS;

ANIMALS; DRUG IMPLANTS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN REPLACEMENT THERAPY; FEMALE; MACACA MULATTA; OVARIECTOMY; OVARY; PROGESTERONE; RALOXIFENE; RAPHE NUCLEI; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2C;

EID: 67449088240     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-008-9087-5     Document Type: Article

References (33)

1. D.L. Murphy, Ann. N. Y. Acad. Sci. 600, 282-295 (1990)
2. L. Van de Kar, Annu. Rev. Pharmacol. Toxicol. 31, 289-320 (1991)
3. L.J. Siever, R.S. Kahn, B.A. Lawlor, R.L. Trestman, T.L. Lawrence, E.F. Coccaro, Pharmacol. Rev. 43, 509-525 (1991)
4. E.C. Azmitia, P.J. Gannon, Adv. Neurol. 43, 407-468 (1986)
5. E. Fifa, G. Fillion, Pharmacol. Rev. 44, 401-458 (1992)
6. L. Uphouse, Neurosci. Biobehav. Rev. 21, 679-698 (1997)
7. C.L. Bethea, Neuroendocrinology 57, 1-6 (1993)
8. C.L. Bethea, Neuroendocrinology 60, 50-61 (1994)
9. C. Gundlah, S.G. Kohama, S.J. Mirkes, V.T. Garyfallou, H.F. Urbanski, C.L. Bethea, Mol. Brain Res. 76, 191-204 (2000)
10. C. Gundlah, N.Z. Lu, S.J. Mirkes, C.L. Bethea, Mol. Brain Res. 91, 14-22 (2001)
11. M.J. Tsai, B.W. O'Malley, Ann. Rev. Biochem. 63, 451-486 (1994)
12. C.L. Bethea, N.Z. Lu, C. Gundlah, J.M. Streicher, Front. Neuroendocrinol. 23, 41-100 (2002)
13. L.J. Smith, J.A. Henderson, C.W. Abell, C.L. Bethea, Neuropsychopharmacology 29, 2035-2045 (2004)
14. R.L. Sanchez, A.P. Reddy, M.L. Centeno, J.A. Henderson, C.L. Bethea, Brain Res. Mol. Brain Res. 135, 194-203 (2005)
15. N.M. Barnes, T. Sharp, Neuropharmacology 38, 1083-1152 (1999)
16. R. Liu, T. Jolas, G. Aghajanian, Brain Res. 873, 34-45 (2000)
17. M. Pecins-Thompson, C.L. Bethea, Neuroscience 89, 267-277 (1998)
18. N.Z. Lu, C.L. Bethea, Neuropsychopharmacology 27, 12-24 (2002)
19. C. Gundlah, M. Pecins-Thompson, W.E. Schutzer, C.L. Bethea, Brain Res. Mol. Brain Res. 63, 325-339 (1999)
20. C.N. Epperson, K.L. Wisner, B. Yamamoto, Psychosom. Med. 61, 676-697 (1999)
21. M.K. Osterlund, M.R. Witt, J.A. Gustafsson, Endocrine 28, 235-242 (2005)
22. J.K. Williams, E.K. Honore, M.R. Adams, Circulation 96, 1970-1975 (1997)
23. B.E.H. Sumner, G. Fink, Mol. Cell Neurosci. 4, 83-92 (1993)
24. B.E. Sumner, K.E. Grant, R. Rosie, C. Hegele-Hartung, K.H. Fritzemeier, G. Fink, Brain Res. Mol. Brain Res.73, 119-128 (1999)
25. M. Cyr, R. Bosse, T. Di Paolo, Neuroscience 83, 829-836 (1998)
26. R.B. Gibbs, Neuroscience 101, 931-938 (2000)
27. T.B. Clarkson, J.M. Cline, J.K. Williams, M.S. Anthony, Osteoporos. Int. 7(Suppl 1), 43-51 (1997)
28. M.R. Adams, J.R. Kaplan, S.B. Manuck, D.R. Koritnik, J.S. Parks, M.S. Wolfe, T.B. Clarkson, Arteriosclerosis 10, 1051-1057 (1990)
29. H.S. Jacobs, Medscape Womens Health 5, E2 (2000)
30. R. Strickler, D.W. Stovall, D. Merritt, W. Shen, M. Wong, S.L. Silfen, Obstet. Gynecol. 96, 359-365 (2000)
31. P. Florio, B. Quirici, E. Casarosa, I. Lombardi, M. Luisi, A.D. Genazzani, F. Petraglia, A.R. Genazzani, Gynecol. Endocrinol. 15, 359-366 (2001)
32. C.L. Bethea, S.J. Mirkes, A. Su, D. Michelson, Psychoneuroendocrinology 27, 431-445 (2002)
33. M.M. Bradford, Analytical Biochem. 72, 248-254 (1976)